You are here

Article info

Article menu
XML
Oncology
Research
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B

Authors

  1. Correspondence to Dr Yutaka Maeda; yutaka.maeda{at}cchmc.org; Dr Takeshi Nagayasu; nagayasu@nagasaki-u.ac.jp
View Full Text

Citation

Wakata K, Tsuchiya T, Tomoshige K, et al
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B
BMJ Open 2015;5:e008366. doi: 10.1136/bmjopen-2015-008366

Publication history

  • Received March 30, 2015
  • Revised May 8, 2015
  • Accepted May 13, 2015
  • First published July 29, 2015.
Online issue publication 
October 26, 2017
Previous versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/